FDA Allows Marketing of Test to Identify Organisms That Cause Bloodstream Infections and Provide Antibiotic Sensitivity Results.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 11, p. i, doi. 10.1093/cid/cix261
- By:
- Publication type:
- Article